Abstract
Background: Health-related quality of life (HRQOL) is multidimensional and subjective, encompassing occupational and physical function, psychological state, social interaction, and somatic sensation. Because of the wide scope of HRQOL and its implications for the medical management of prostate cancer survivors, clinicians and researchers need to know the most reliable and valid measures currently available for addressing this clinical construct in men diagnosed with prostate cancer. Purpose: To identify and evaluate patient-reported outcome measures used to assess HRQOL in men diagnosed with prostate cancer and make recommendations for the use of these patient-reported outcome measures in both the research and clinic settings. Methods: The literature was systematically reviewed for patient-reported outcome measures used in peer-reviewed, published research to assess HRQOL in men diagnosed with prostate cancer. The goals were to examine the psychometric properties of commonly used HRQOL measures in order to determine their clinical utility. Results: The following patient-reported outcome measures are highly recommended by the Task Force to assess HRQOL in men diagnosed with prostate cancer: EORTC QLQ-P25 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Prostate 25), EPIC (Expanded Prostate Cancer Index Composite), FACT-P (Functional Assessment of Cancer Therapy-Prostate), UCLA-PCI (UCLA-Prostate Cancer Index), EORTC QLQ-C30 (EORTC Quality of Life Questionnaire-Cancer 30), FACT-G (Functional Assessment of Cancer Therapy-General), and SF (Short-Form) 36, 12, and 8. Conclusions: A variety of patient-reported outcome measures have been reported in the literature to assess HRQOL in men diagnosed with prostate cancer. Seven measures were found to have satisfactory psychometric properties, as well as good clinical utility, and are recommended for use by the researchers on this Task Force.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 27-35 |
| Number of pages | 9 |
| Journal | Rehabilitation Oncology |
| Volume | 34 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 2016 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Rehabilitation
- Oncology
- Oncology(nursing)
- Physical Therapy, Sports Therapy and Rehabilitation
Cite this
Oncology section EDGE task force on prostate cancer : A systematic review of outcome measures for health-related quality of life. / Harrington, Shana; Lee, Jeannette; Colon, Genevieve; Alappattu, Meryl.
In: Rehabilitation Oncology, Vol. 34, No. 1, 01.01.2016, p. 27-35.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Oncology section EDGE task force on prostate cancer
T2 - A systematic review of outcome measures for health-related quality of life
AU - Harrington, Shana
AU - Lee, Jeannette
AU - Colon, Genevieve
AU - Alappattu, Meryl
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Background: Health-related quality of life (HRQOL) is multidimensional and subjective, encompassing occupational and physical function, psychological state, social interaction, and somatic sensation. Because of the wide scope of HRQOL and its implications for the medical management of prostate cancer survivors, clinicians and researchers need to know the most reliable and valid measures currently available for addressing this clinical construct in men diagnosed with prostate cancer. Purpose: To identify and evaluate patient-reported outcome measures used to assess HRQOL in men diagnosed with prostate cancer and make recommendations for the use of these patient-reported outcome measures in both the research and clinic settings. Methods: The literature was systematically reviewed for patient-reported outcome measures used in peer-reviewed, published research to assess HRQOL in men diagnosed with prostate cancer. The goals were to examine the psychometric properties of commonly used HRQOL measures in order to determine their clinical utility. Results: The following patient-reported outcome measures are highly recommended by the Task Force to assess HRQOL in men diagnosed with prostate cancer: EORTC QLQ-P25 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Prostate 25), EPIC (Expanded Prostate Cancer Index Composite), FACT-P (Functional Assessment of Cancer Therapy-Prostate), UCLA-PCI (UCLA-Prostate Cancer Index), EORTC QLQ-C30 (EORTC Quality of Life Questionnaire-Cancer 30), FACT-G (Functional Assessment of Cancer Therapy-General), and SF (Short-Form) 36, 12, and 8. Conclusions: A variety of patient-reported outcome measures have been reported in the literature to assess HRQOL in men diagnosed with prostate cancer. Seven measures were found to have satisfactory psychometric properties, as well as good clinical utility, and are recommended for use by the researchers on this Task Force.
AB - Background: Health-related quality of life (HRQOL) is multidimensional and subjective, encompassing occupational and physical function, psychological state, social interaction, and somatic sensation. Because of the wide scope of HRQOL and its implications for the medical management of prostate cancer survivors, clinicians and researchers need to know the most reliable and valid measures currently available for addressing this clinical construct in men diagnosed with prostate cancer. Purpose: To identify and evaluate patient-reported outcome measures used to assess HRQOL in men diagnosed with prostate cancer and make recommendations for the use of these patient-reported outcome measures in both the research and clinic settings. Methods: The literature was systematically reviewed for patient-reported outcome measures used in peer-reviewed, published research to assess HRQOL in men diagnosed with prostate cancer. The goals were to examine the psychometric properties of commonly used HRQOL measures in order to determine their clinical utility. Results: The following patient-reported outcome measures are highly recommended by the Task Force to assess HRQOL in men diagnosed with prostate cancer: EORTC QLQ-P25 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Prostate 25), EPIC (Expanded Prostate Cancer Index Composite), FACT-P (Functional Assessment of Cancer Therapy-Prostate), UCLA-PCI (UCLA-Prostate Cancer Index), EORTC QLQ-C30 (EORTC Quality of Life Questionnaire-Cancer 30), FACT-G (Functional Assessment of Cancer Therapy-General), and SF (Short-Form) 36, 12, and 8. Conclusions: A variety of patient-reported outcome measures have been reported in the literature to assess HRQOL in men diagnosed with prostate cancer. Seven measures were found to have satisfactory psychometric properties, as well as good clinical utility, and are recommended for use by the researchers on this Task Force.
UR - http://www.scopus.com/inward/record.url?scp=84984645357&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84984645357&partnerID=8YFLogxK
U2 - 10.1097/01.REO.0000000000000004
DO - 10.1097/01.REO.0000000000000004
M3 - Article
VL - 34
SP - 27
EP - 35
JO - Rehabilitation Oncology
JF - Rehabilitation Oncology
SN - 2168-3808
IS - 1
ER -